摘要
患者的自我管理在糖尿病的治疗中意义重大,在我国当前的医疗条件下,选择一种依从性高的治疗方案,对于提高患者的自我管理水平,进而改善达标现状具有非常关键的作用。临床研究,门冬胰岛素30可全面降低血糖、安全性佳、治疗性价比高且注射方法简单,满足高依从性治疗方案的多项要求。
Patient-based compliance contributes to significance of diabetic therapeutics. In current medical conditions of China, choosing therapeutic strategy with high-compliance would play significant role in enforcing self-management and improving treat-to-target blood glucose management. Clinical trials indicated that, insulin aspart 30 achieved blood glucose control and excellent safety. Furthermore, high cost effectiveness and simply injection performance by insulin aspart 30 meet the need of high- compliance-based clinical therapeutic strategy.
作者
冯波
FENG Bo(Department of Endocrinology, East Hospital Affiliated to Tongji University, Shanghai 200120, China)
出处
《药品评价》
CAS
2016年第19期31-34,共4页
Drug Evaluation
关键词
糖尿病
门冬胰岛素30
临床疗效
依从性
Diabetes
Insulin Aspart 30
Clinical Efficacy
Patient-Based
Compliance